Interleukin-1 receptor-related protein ST2 and mitral valve repair outcome in patients with chronic degenerative mitral regurgitation

Thoracic and Cardiovascular Surgeon

Volumn 62, Issue 1, 2014, Pages 47-51

  Galeone, Antonella ^a,b   Lessana, Arrigo ^b   Mascolo, Elisa ^c   Di Serio, Francesca ^c   Marraudino, Nicola ^a   Laborde, Francois ^b   Paparella, Domenico ^a  

^a UNIVERSITY OF BARI   (Italy)

^b INSTITUT MUTUALISTE MONTSOURIS   (France)

^c POLICLINICO   (Italy)

Author keywords

mitral valve regurgitation; mitral valve repair; ST2

Indexed keywords

AGED; BIOLOGICAL MARKERS; CARDIAC SURGICAL PROCEDURES; CHRONIC DISEASE; ECHOCARDIOGRAPHY, DOPPLER, COLOR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; MITRAL VALVE INSUFFICIENCY; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; RECEPTORS, CELL SURFACE; SEVERITY OF ILLNESS INDEX; STROKE VOLUME; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 84895059363     PISSN: 01716425     EISSN: 14391902     Source Type: Journal    
DOI: 10.1055/s-0033-1356751     Document Type: Article

References (17)

1. Tominaga Si, Kuroiwa K., Tago K., Iwahana H., Yanagisawa K., Komatsu N. Presence and expression of a novel variant form of ST2 gene product in human leukemic cell line UT-7/GM. Biochem Biophys Res Commun: 1999; 264 1 14 18
2. Tominaga S. A putative protein of a growth specific cDNA from BALB/c-3T3 cells is highly similar to the extracellular portion of mouse interleukin 1 receptor. FEBS Lett: 1989; 258 2 301 304
3. Weinberg E. O., Shimpo M., De Keulenaer G. W., et al. Expression and regulation of ST2, an interleukin-1 receptor family member, in cardiomyocytes and myocardial infarction. Circulation: 2002; 106 23 2961 2966
4. Sanada S., Hakuno D., Higgins L. J., Schreiter E. R., McKenzie A. N., Lee R. T. IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system. J Clin Invest: 2007; 117 6 1538 1549
5. Shimpo M., Morrow D. A., Weinberg E. O., et al. Serum levels of the interleukin-1 receptor family member ST2 predict mortality and clinical outcome in acute myocardial infarction. Circulation: 2004; 109 18 2186 2190
6. Weinberg E. O., Shimpo M., Hurwitz S., Tominaga S., Rouleau J. L., Lee R. T. Identification of serum soluble ST2 receptor as a novel heart failure biomarker. Circulation: 2003; 107 5 721 726
7. Sabatine M. S., Morrow D. A., Higgins L. J., et al. Complementary roles for biomarkers of biomechanical strain ST2 and N-terminal prohormone B-type natriuretic peptide in patients with ST-elevation myocardial infarction. Circulation: 2008; 117 15 1936 1944
8. Mueller T., Dieplinger B., Gegenhuber A., Poelz W., Pacher R., Haltmayer M. Increased plasma concentrations of soluble ST2 are predictive for 1-year mortality in patients with acute destabilized heart failure. Clin Chem: 2008; 54 4 752 756
9. Xu D., Chan W. L., Leung B. P., et al. Selective expression of a stable cell surface molecule on type 2 but not type 1 helper T cells. J Exp Med: 1998; 187 5 787 794
10. Oshikawa K., Kuroiwa K., Tago K., et al. Elevated soluble ST2 protein levels in sera of patients with asthma with an acute exacerbation. Am J Respir Crit Care Med: 2001; 164 2 277 281
11. Tajima S., Oshikawa K., Tominaga S., Sugiyama Y. The increase in serum soluble ST2 protein upon acute exacerbation of idiopathic pulmonary fibrosis. Chest: 2003; 124 4 1206 1214
12. Beltrán C. J., Núñez L. E., Díaz- Jiménez D., et al. Characterization of the novel ST2/IL-33 system in patients with inflammatory bowel disease. Inflamm Bowel Dis: 2010; 16 7 1097 1107
13. Brunner M., Krenn C., Roth G., et al. Increased levels of soluble ST2 protein and IgG1 production in patients with sepsis and trauma. Intensive Care Med: 2004; 30 7 1468 1473
14. Palmer G., Talabot-Ayer D., Lamacchia C., et al. Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis. Arthritis Rheum: 2009; 60 3 738 749
15. Yin H., Huang B. J., Yang H., et al. Pretreatment with soluble ST2 reduces warm hepatic ischemia/reperfusion injury. Biochem Biophys Res Commun: 2006; 351 4 940 946
16. Enriquez-Sarano M., Akins C. W., Vahanian A. Mitral regurgitation. Lancet: 2009; 373 9672 1382 1394
17. Szerafin T., Niederpold T., Mangold A., et al. Secretion of soluble ST2 - possible explanation for systemic immunosuppression after heart surgery. Thorac Cardiovasc Surg: 2009; 57 1 25 29